Market Place
Sourcing Support
Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Benefit
11 Dec 2024 //
PRESS RELEASE
Arvinas & Pfizer Present Ph 1b Data on Vepdegestrant at SABCS 2024
10 Dec 2024 //
GLOBENEWSWIRE
Incyclix Bio Announces Trial Collaboration with Lilly for INX-315
18 Nov 2024 //
GLOBENEWSWIRE
Lilly to Present Imlunestrant Results at Breast Cancer Symposium
01 Nov 2024 //
PR NEWSWIRE
Lilly Oncology Asco Details: 2024 Annual Meeting Presentations
23 May 2024 //
PR NEWSWIRE
ASCO: Lilly seeks prostate cancer redemption after Verzenio flop
23 May 2024 //
FIERCE PHARMA
Eli Lilly reports 67% increase in Q1 2024 net income
01 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Lilly’s growth drivers, Verzenio and Jardiance, suffer setbacks
01 May 2024 //
FIERCE PHARMA
Eli Lilly hit with Verzenio flop in prostate cancer
07 Feb 2024 //
FIERCE PHARMA
Lilly axes PhIII trial of Verzenio in prostate cancer
06 Feb 2024 //
ENDPTS
Lilly to Present Final Overall Survival Analysis from MONARCH 3 Study of Verzenio
06 Dec 2023 //
PR NEWSWIRE
eFFECTOR Receives U.S. FDA Fast Track Designation for Zotatifin
28 Nov 2023 //
GLOBENEWSWIRE
Outcome Data Demonstrate Verzenio`s Impact on Cancer Recurrence in Breast Cancer
20 Oct 2023 //
PR NEWSWIRE
Boundless Announces Clinical Trial Collaboration and Supply Agreement with Lilly
19 Sep 2023 //
BUSINESSWIRE
Lilly Highlights Verzenio and Jaypirca Data at 2023 ASCO Annual Meeting
02 Jun 2023 //
PR NEWSWIRE
eFFECTOR reports interim data updates from cancer combo expansion cohort
26 May 2023 //
CLINICAL TRIALS ARENA
U.S. FDA Broadens Indication for Verzenio in HR+, HER2 Early Breast Cancer
03 Mar 2023 //
PR NEWSWIRE
Lilly aims at broader adjuvant breast cancer nod
07 Dec 2022 //
FIERCEPHARMA
Lilly Announces Data from the Verzenio Phase 3 monarchE Trial
06 Dec 2022 //
PRNEWSWIRE
SABCS: Lilly aims at broader adjuvant breast cancer nod
06 Dec 2022 //
FIERCEPHARMA
Lilly`s Verzenio wins NICE backing in adjuvant breast cancer
22 Jun 2022 //
FIERCEPHARMA
NICE recommends Eli Lilly’s breast cancer therapy
17 Jun 2022 //
PHARMATIMES
MHRA marketing authorisation granted for Lilly’s Verzenios
17 May 2022 //
PHARMATIMES
Veru Enters in Collaboration and Supply Agreement with Eli Lilly for Enobosarm
01 Feb 2022 //
GLOBENEWSWIRE
Additional Verzenio® (abemaciclib) Phase 3 monarchE Trial Data
28 Oct 2021 //
PRNEWSWIRE
Lilly Announces Updated Verzenio®Phase 3 monarchE Trial Data Presented at ESMO
14 Oct 2021 //
PRNEWSWIRE
Lilly wins the breast cancer adjuvant race
13 Oct 2021 //
EVALUATE
Care Access and Eli Lilly Partner to Increase Diversity Within Oncology Trials
28 Sep 2021 //
BUSINESSWIRE
New Data from Verzenio® monarchE Study to Be Featured in ESMO Virtual Plenary
27 Sep 2021 //
PRNEWSWIRE
NICE approval for Lilly`s Verzenios is “fantastic news for thousands of women”
13 Aug 2021 //
PMLIVE
NICE approval for Lilly`s Verzenios is “fantastic news for many womenâ€
12 Aug 2021 //
PM LIVE
NICE approval for Lilly`s Verzenios is “fantastic news for thousands of women”
12 Aug 2021 //
PM LIVE
Breast cancer drug approved for NHS after maker agrees discount
12 Aug 2021 //
THEGUARDIAN
After years of buzz, continuous manufacturing is gaining steam
01 Jun 2021 //
FIERCEPHARMA
Lilly`s Verzenio eyes $4B with early breast cancer win: analyst
03 Mar 2021 //
FIERCE PHARMA
NICE rejects Lilly’s Verzenios for advanced breast cancer
15 Feb 2021 //
PHARMATIMES
Abemaciclib Cuts Early Recurrence in High-risk Breast Cancer
22 Sep 2020 //
MEDSCAPE
Abemaciclib + HT for high-risk early breast cancer reduces recurrence by 25%
22 Sep 2020 //
JOURNAL
Lilly`s Verzenio pressures Pfizer with practice win in early breast cancer
21 Sep 2020 //
FIERCE PHARMA
Verzenio® Data Shows Reducetion Of Risk Of Cancer Recurrence By 25%
20 Sep 2020 //
PRNEWSWIRE
Lilly Announces Drug-Therapy Combo Cuts Breast Cancer Recurrence Risk By 25%
20 Sep 2020 //
FOX NEWS
Addition Of Tamoxifen To Abemaciclib Improves OS In Metastatic Breast Cancer
20 Sep 2020 //
ESMO
Zentalis Pharmaceuticals Enters into Clinical Collaboration with Eli Lilly
27 Jul 2020 //
GLOBENEWSWIRE
Sermonix to Collaborate With Eli Lilly & Company in Studying Combo Lasofoxifene
08 Jul 2020 //
GLOBENEWSWIRE
Lilly`s Verzenio shows up Ibrance, hitting its goal Pfizer`s drug faltered
17 Jun 2020 //
FIERCE PHARMA
AllianceRx Walgreens Prime studies the use of cyclin kinase 4/6 inhibs
11 May 2020 //
PR NEWSWIRE
FDA’s Project Orbis May Expand to Singapore and Switzerland
13 Nov 2019 //
RAPS
Novartis, Eli Lilly marquee positive survival data for CDK 4/6 franchises
29 Sep 2019 //
ENDPTS
FDA collaborates with Health Canada, Australia to approve new cancer drugs
18 Sep 2019 //
ENDPTS
FDA Collaborates With Health Canada, Australia to Approve New Cancer Drugs
18 Sep 2019 //
RAPS
FDA Warns of Possible Interstitial Lung Disease, Pneumonitis,Breast Cancer Drugs
16 Sep 2019 //
CANCERTHERAPYADVISOR
Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation
13 Sep 2019 //
RAPS
Lilly boosted by survival data for key growth drug Verzenio
01 Aug 2019 //
PMLIVE
Lilly`s Verzenio combo show additional breast cancer survival benefit in new Ph3
01 Aug 2019 //
PHARMAFILE
Eli Lilly announces Verzenio survival benefit
01 Aug 2019 //
PHARMATIMES
Novartis’ Kisqali, trailing Lilly’s Verzenio, nabs limited NICE backing
17 Jul 2019 //
FIERCE PHARMA
Japan`s health ministry warns of serious side effects of Lilly`s Verzenio
23 May 2019 //
PHARMAFILE
Another Eli Lilly oncology drug is in trouble, Japan safety warning Verzenio
22 May 2019 //
ENDPTS
Lilly`s rising star Verzenio gets Japanese safety warning
22 May 2019 //
FIERCE PHARMA
